Revolution in cancer treatment: Psilocybin prevents nerve damage from chemotherapy

A revolutionary scientific success has been achieved in the world of oncology and neurology, which will completely change the quality of life of cancer patients. Platinum-based chemotherapy drugs used in cancer treatment cause "peripheral neuropathy", known as "peripheral neuropathy", in approximately 60 percent of patients; It caused pins and needles in the hands and feet, a severe burning sensation, and permanent nerve damage. A clinical study published in the respected scientific journal Science documented that the psychoactive compound psilocybin found in magic mushrooms completely prevents this severe condition when applied before chemotherapy.

"NEURON STARVING" IS PREVENTED AT THE CELLULAR LEVEL

Chemotherapy drugs stop the movement of mitochondria in sensory nerve cells that extend to the outer layers of the skin, causing neurons to lack energy and decay over time. In experimental studies, it was determined that only two doses of psilocybin administered before the eight-month chemotherapy process protected the flow of mitochondria in nerve cells and prevented the death of nerve endings.

It was noted that the compound directly protects sensory nerve fibers without any negative impact on the tumor-shrinking ability or cancer-fighting power of chemotherapy.

TREATMENT POSSIBILITY WITHOUT HALLUCINATION EXPERIENCE

MD Anderson Cancer Center experts who conducted the research revealed that psilocybin can provide this protective effect without creating a psychoactive process ("trip") in the brain. A similar high level of neuroprotection was obtained in tests conducted with the substance "tabernantolog", which activates the same receptors and does not have a hallucinatory effect.

In order to examine the effect of the method on human tissues, nerve tissues taken from 29 patients who underwent surgery were examined under a microscope. It has been proven that in tissues treated with psilocybin, the cellular arrest caused by chemotherapy did not occur and organelle mobility continued completely.

HUMAN CLINICAL TRIALS ARE BEING STARTED

Following the successful results, the medical world set a fast schedule. The first phase of human clinical trials aiming to measure the safety and effectiveness of psilocybin use before chemotherapy in cancer patients is being initiated.

Experts remind that with the development of cancer treatments, the life expectancy of patients has increased, but the chronic side effects remaining after the treatment make life unbearable. It is emphasized that the method will offer a double therapeutic advantage, as it provides neurological protection and reduces depression and anxiety, which are frequently seen in cancer patients.